✦ LIBER ✦

A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season

✍ Scribed by Pilar Fernández; Adrian Trenholme; Katia Abarca; M Pamela Griffin; Micki Hultquist; Brian Harris; Genevieve A Losonsky; the Motavizumab Study Group

Book ID: 115011869
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 678 KB
Volume: 10
Category: Article
ISSN: 1471-2431
DOI: 10.1186/1471-2431-10-38

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-blind, randomized, placebo-cont

A Double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-infected

✍ Gardner, Stephen; Cutrell, Amy; Elko-Simms, Cindy; Adkison, Kimberly; Hamatake, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB